Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

SNS 2.0: The Next Generation

Building a More Resilient Strategic National Stockpile


The SNS Mission: Past and Present

Prior to COVID-19, planning for a Strategic National Stockpile (SNS) response primarily focused on regional or localized emergencies such as natural disasters or terrorist attacks.

The COVID-19 pandemic revealed vulnerabilities in the global medical supply chain that required the Department of Health and Human Services (HHS) to reassess, replenish and restructure the SNS to better protect the health and safety of all Americans.

A warehouse view of the Strategic National Stockpile

The next generation of the SNS will have the breadth and depth to meet the ongoing needs of COVID-19 as well as any future pandemic or public health emergency on a national scale. These changes and upgrades will bolster the U.S. industrial base for producing critical pharmaceuticals and medical supplies and, most importantly, will reduce America’s reliance on foreign suppliers and manufacturers. SNS 2.0 will ensure we are ready and resilient when the country needs us.


SNS 2.0: The Next Generation

By fall 2020, HHS will achieve a capacity to meet 90 days of the most critical supplies for the COVID-19 response needs of the U.S. healthcare system.

To reach this goal, actions are underway to increase the supply of personal protective equipment (PPE) and other critical items in the SNS, in the commercial supply chain, and at the point of use, such as hospitals.


SNS 2.0 Priorities

The SNS will focus on five priority areas to bolster national health security and ensure readiness:

The five priority areas of the SNS infographic

Replenishing the SNS

  • PPE such as N95 respirators, surgical/face masks, gowns and coveralls, gloves, eye protection, and more
  • Pharmaceuticals for intensive care use
  • Testing supplies and equipment

Refining SNS strategy and structure

  • Revise the types of products and supplies needed by the SNS
  • Determine quantity of products and supplies needed for a variety of public health threats

Establishing a distributor working model

  • Collaborate with commercial partners to upgrade process of transporting supplies during a nationwide response
  • Determine where product is needed in many geographic areas simultaneously

Expanding the supply chain control tower

  • Inform decision making for balancing supply and demand in emergencies
  • Provide greater visibility on supplies from manufacturing to end user

Expanding domestic manufacturing

  • Ensure the United States can produce its medical supplies stateside
  • Prioritize production of COVID-related items like PPE and testing supplies without a significant reliance on foreign manufacturers

Contact Us

For further questions or information about the Strategic National Stockpile (SNS), please email us at sns.ops@cdc.gov

  • This page last reviewed: September 01, 2020